Viewing Study NCT02508467


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-24 @ 2:08 PM
Study NCT ID: NCT02508467
Status: COMPLETED
Last Update Posted: 2024-04-12
First Post: 2015-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Sponsor: Blueprint Medicines Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module